[1] MOZAFFARIAN D,BENJAMIN E J,GO A S,et al.Heart Disease and Stroke Statistics-2016 Update:a report from the American Heart Association[J].Circulation,2016,133(4):338-360.
[2] STREETEN E A.Bone as a classic endocrine organ:Interactions with non-bone tissues[J].Rev Endocr Metab Disord,2015,16(2):77-78.
[3] LEE N K,SOWA H,HINOI E,et al.Endocrine regulation of energy metabolism by the skeleton[J].Cell,2007,130:456-469.
[4] DOU J,LI H,MA X,et al.Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway[J].Cardiovasc Diabetol,2014,13:74.
[5] JUNG C H,LEE W J,HWANG J Y,et al.The preventive effect of uncarboxylated osteocalcin against free fatty acid-induced endothelial apoptosis through the activation of phosphatidylinositol 3-kinase/Akt signaling pathway[J].Metabolism,2013,62(9):1250-1257.
[6] FOUGERAT A,GAYRAL S,GOURDY P,et al.Genetic and pharmacological targeting of phosphoinositide 3-kinase-{gamma} reduces atherosclerosis and favors plaque stability by modulating inflammatory processes[J].Circulation,2008,117:1310-1317.
[7] LUPIERI A,SMIRNOVA N,MALET N,et al.PI3K signaling in arterial diseases:Non redundant functions of the PI3K isoforms[J].Adv Biol Regul,2015,59:4-18.
[8] ROTLLAN N,WANSCHEL A C,FERNÁNDEZ-HERNANDO A,et al.Genetic evidence supports a major role for Akt1 in VSMCs during atherogenesis[J].Circ Res,2015,116(11):1744-1752.
[9] BINI A,MANN K G,KUDRYK B J,et al.None collagenous bone matrix proteins,calcification,and thrombosis in carotid artery atherosclero-sis[J].Arterioscler Thromb Vasc Biol,1999,19(8):1852-1861.
[10] 顾钰霞,刘乃丰.内皮祖细胞在冠状动脉粥样硬化性心脏病中的作用研究进展[J].东南大学学报:医学版,2014,33(3):354-358.
[11] 刘力,李芬娥,王雅杰.循环内皮祖细胞异位表达骨钙素在缺血性脑血管病发病中的作用[J].中国卒中杂志,2011,6(9):711-716.
[12] GOSSL M,MODDER U I,GULATI R,et al. Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells[J].Eur Heart J,2010,31:2909-2914.
[13] YANG S W,HENNESSY R R,KHOSLA S,et al.Circulating osteogenic endothelial progenitor cell counts:new biomarker for the severity of coronary artery disease[J].Int J Cardiol,2017,227:833-839.
[14] PI M,WU Y,QUARLES L D,et al.GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo[J].J Bone Miner Res,2011,26:1680-1683.
[15] DHORE C R,CLEUTJENS J P,LUTGENS E,et al.Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques[J].Arterioscler Thromb Vasc Biol,2001,21:1998-2003.
[16] HOLVIKK,van SCHOOR N M,EEKHOFF E M,et al.Plasma osteocalcin levels as a predictor of cardiovascular disease in older men and women:a population-based cohort study[J].Eur J Endocrinol,2014,171(2):161-170.
[17] KIM K J,KIM K M,PARK K H,et al.Aortic calcification and bone metabolism:the relationship between aortic calcification,BMD,vertebral fracture,25-hydroxyvitamin D,and osteocalcin[J].Calcif Tissue Int,2012,91(6):370-378.
[18] HU W W,KE X H,HE J W,et al.Serum osteocalcin levels are inversely associated with plasma glucose and body mass index in healthy Chinese women[J].Acta Pharmacol Sin,2014,35(12):1521-1526.
[19] GUEDES J A C,ESTEVES J V,MORAIS M R,et al.Osteocalcin improves insulin resistance and inflammation in obese mice:Participation of white adipose tissue and bone[J].Bone,2017,pii:S8756-3282(17):30439-8.
[20] IGLESIAS P,ARRIETA F,PIERA M,et al.Serum con-centrations of osteocalcin,procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance[J].Clin Endocrinol (Oxf),2011,75:184-188.
[21] RESHMI S,SHERITA H G,KATHRYN A C,et al.Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study[J].J Clin Endocrinol Metab,2015,100(4):1602-1608.
[22] GOETZ L G,MAMILLAPALLI R,SAHIN C,et al.Addition of estradiol to cross-sex testosterone therapy reduces atherosclerosis plaque formation in female ApoE -/-Mice[J].Endocrinology,2017,159(2):754-762.
[23] OURY F,SUMARA G,SUMARA O,et al.Endocrine regulation of male fertility by the skeleton[J].Cell,2011,144:796-809.
[24] MILLER V M,DUCKLES S P.Vascular actions of estrogens:functional implications[J].Pharmacol Rev,2008,60(2):210-241.
[25] SHANBHOGUE V V,HANSEN S,FROST M,et al.Bone disease in diabetes:another manifestation of microvascular disease?[J].Lancet Diabetes Endocrinol,2017,5(10):827-838.
[26] LIM Y,CHUN S,LEE J H,et al.Association of bone mineral density and diabetic retinopathy in diabetic subjects:the 2008-2011 Korea National Health and Nutrition Examination Survey[J].Osteoporos Int,2016,27(7):2249-2257.
[27] MAGHBOOLI Z,SHABANI P,GORGANI-FIRUZJAEE S,et al.The association between bone turnover markers and microvascular complications of type 2 diabetes[J].J Diabetes Metab Disord,2016,15:51. |
